MERCED - There’s a bridge to be crossed before stem cell
therapies are ready for widespread use, according to Professor
Jennifer O. Manilay at the University of California, Merced.
Tissues derived from embryonic stem cells are unlikely to be an
immunological match for their intended recipients,...